APAC Insulin Market


  • Type: Common Disease Area
  • Published : October 2021
  • Region: APAC
  • Country: Other
  • Report ID : 4981

  • Format: PPT, PDF

Segmented by Product Analysis, Procedure Analysis, Source Analysis and Regional Analysis – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

SKU: 4981 Categories: ,

Report Description of the APAC Insulin Market

Research Scope and Assumption
• The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
• The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
• We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
• All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
• Inflation has not been accounted for in order to estimate and forecast the market
• Numbers may not add up due to rounding off

Reason to buy the report:

• Facilitate decision-making based on strong current and forecast data for APAC Insulin Market
• Develop strategies based on the latest regulatory framework
• Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
• Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Insulin Market
• Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
• To strategically profile key players and comprehensively analyze their market shares and core competencies
• We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

APAC Insulin Market Executive Summary

Insulin is a hormone, which facilitates the entry of glucose into the blood cells. The body’s inability to produce an appropriate amount of insulin leads to the accumulation of sugar in the bloodstream leading to a rise in blood sugar levels and eventually diabetes. The growing global prevalence of diabetes and the increasing incidence rates of lifestyle-induced disorders such as obesity.
Growing regional prevalence of diabetes, increasing market penetration rates of modern insulin products in emerging markets such as India and China are expected to drive market growth during the forecast period. Furthermore, patent expiration of key products such as Lantus is expected to trigger the manufacturing of biosimilars from local manufacturers such as Biocon.

Market Size and Key Findings

The APAC Insulin Market size stood at around $15.4 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The presence of a strong product pipeline portfolio and the future commercialization of these products is expected to serve this market as a future growth opportunity. The Asia Pacific insulin market is dominated by three major companies including Novo Nordisk, Eli Lilly, and Sanofi Aventi.

Market Dynamics

Market Growth Drivers Analysis

Growing regional prevalence of diabetes, increasing market penetration rates of modern insulin products in emerging markets such as India and China are expected to drive market growth during the forecast period.

Market Restraints

Since, the Asian countries reside majorly in the middle-income group, diagnosis and treatment of diabetes does not reach to a large part of the population. Lack of awareness and affordability are the biggest hindrance. The world’s largest diabetic population resides in Asia Pacific due to which the demand for insulin is on a constant rise. Japan, China and India are the important markets in the region.

COVID-19 impact on “APAC Insulin Market”

Amidst the pandemic situation, APAC Insulin Market has been hindered as every industry got a worst hit by COVID. But APAC Insulin Market is quickly reaching its pre-COVID levels and a healthy growth rate is expected over the forecast period driven by the V-shaped recovery in most of the developing nations.

Competitive Landscape

Key Players

The “APAC Insulin Market” study report will provide valuable insights with an emphasis on the APAC market including some of the key market players such as Novo Nordisk, Eli Lilly and Company, Sanofi Aventis, Takeda Pharmaceuticals, Oramed Pharmaceuticals, Nanjing Xinbai Pharmaceutical Co. Ltd. and Boehringer Ingelheim.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and revenue analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players.

Notable Recent Deals

Korean biosimilar firm Celltrion’s USD 266 million acquisition of Japanese outfit Takeda assets in the Asia-Pacific region. The new global strategy for Takeda is centred on four core therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience, and Rare Diseases, with some allowances for targeted R&D investments into other areas like Plasma-Derived Therapies (PDT) and Vaccines.

1. Report Description of the APAC Insulin Market……………
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Insulin Market Executive Summary………………………
2.1 APAC Insulin Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Insulin Market……………………
3.1 Market Growth Drivers Analysis
3.1.1 Growing regional prevalence of diabetes
3.1.2 Increasing market penetration rates
3.2 Market Restraints Analysis
3.2.1 Asian countries reside in the middle-income group
3.2.2 Hindrance in reaching of treatment
3.3 Covid-19 Market Impact Analysis
4. APAC Insulin Market Segmentation………………………………………
4.1 By Product Analysis:
4.1.1 Rapid acting
4.1.2 Long acting
4.1.3 Premixed
4.1.4 Premixed analog
4.1.5 Short acting
4.1.6 Intermediate acting
4.2 By Procedure Analysis:
4.2.1 Type I and Other Diabetes
4.2.2 Type II Diabetes
4.3 By Source Analysis:
4.3.1 Human Recombinant
4.3.2 Analogs
4.4 By Regional Analysis:
4.4.1 India
4.4.2 China
4.4.3 Australia
4.4.4 New Zealand
4.4.5 South Korea
4.4.6 Taiwan
4.4.7 Philippines
4.4.8 Vietnam
4.4.9 Indonesia
4.4.10 Japan
4.4.11 Malaysia
4.4.12 Thailand
4.4.13 Rest of Asia Pacific
5. APAC Insulin Market Share………………………………………
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
6.1 Major Top Market Players
6.2 R&D Initiatives in APAC Insulin Market
6.3 Notable recent deals in APAC Insulin Market
6.3.1 Joint Ventures
6.3.2 Partnerships
6.3.3 Mergers & Acquisitions
6.3.4 Strategic divestments
7. Key Company Profiles………………………………………………………………….
7.1 Novo Nordisk Company overview
Product & Services, Strategies & Financials
7.2 Eli Lilly and Company Company overview
Product & Services, Strategies & Financials
7.3 Sanofi Aventis Company overview
Product & Services, Strategies & Financials
7.4 Takeda Pharmaceuticals Company overview
Product & Services, Strategies & Financials
7.5 Oramed Pharmaceuticals. Company overview
Product & Services, Strategies & Financials
7.6 Nanjing Xinbai Pharmaceutical Co. Ltd. overview
Product & Services, Strategies & Financials
7.7 Boehringer Ingelheim Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth…………………………………………………………
9.1 New Trends and Development of APAC Insulin Market
9.2 Future Opportunities
10. Strategic Recommendations

By Products:
• Rapid acting
• Long acting
• Premixed
• Premixed analog
• Short acting
• Intermediate acting
Insulin acting analogs dominated the overall product market in terms of revenue. The high prices of long-acting analogs making significant contributions towards the revenue, introduction of advanced products capitalizing on the opportunities available in the developed markets such as Japan and the phasing out of human insulin by modern insulin analogs on the grounds of efficacy.

By Application:
• Type I and Other Diabetes
• Type II Diabetes

By Source:
• Human Recombinant
• Analogs

By Regional:
• India
• Apheresis
• Australia
• New Zealand
• South Korea
• Taiwan
• Philippines
• Vietnam
• Indonesia
• Japan
• Malaysia
• Thailand
• Rest of Asia Pacific
Key countries analysed in this study include India, China, Australia, New Zealand, South Korea, Taiwan, Philippines, Vietnam, Indonesia, Japan, Malaysia, and Thailand. Japan dominated the overall Asia Pacific insulin market with the highest revenue share, owing to the high consumption of innovator brands in this country. Moreover, the presence of high patient disposable income and healthcare expenditure is expected to drive market growth during the forecast period.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements